Calidi Biotherapeutics, Inc. (CLDI)
R&D Expenses
$2.56M
Quarterly · Period ending: · USD
CLDI R&D Expenses
Latest reported$2.56Mperiod ending
Latest reported$2.56Mperiod ending
CLDI Quarterly R&D Expenses ($0.00 → $2.56M)
Quarterly R&D Expenses
High-resolution chart · PNG
CLDI r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 2,558,000 | |
| 2,587,000 | |
| 2,358,000 | |
| 2,361,000 | |
| 2,593,000 | |
| 2,425,000 | |
| 1,815,000 | |
| 2,153,000 | |
| 2,167,000 | |
| 2,743,000 | |
| 3,958,000 | |
| 3,251,000 | |
| 3,177,000 | |
| 2,622,000 | |
| 2,263,000 | |
| 1,945,000 | |
| 1,484,000 | |
| 1,565,000 | |
| 1,246,000 | |
| 0 | |
| 0 |